Breaking News

Hovione enters partnership with Ripple Therapeutics

The move is set to expand the use of Ripple's Epidel platform beyond ophthalmic applications

Catalent and Bhami announce licensing agreement

Catalent will be authorised to collaborate with its customers to evaluate BRL’s formulation technology

Stahl completes acquisition of ICP Industrial Solutions Group

ISG is primarily active in North America (close to 70% of sales), where it is a recognised technical leader

Investment, outsourcing and globalisation: key trends for 2023

The start of 2023 has been challenging for the pharmaceutical industry. Economic constraints in Europe and the United States, staffing shortages, a...

Bluepharma opens industrial facility for high potent drugs

This new unit in Eiras, Coimbra, creates 100 jobs, most of them highly qualified

BES completes $4.8m refurb for Recipharm

The 4000 sqm facility, located in King’s Lynn, has seen an extensive redesign and refurbishment

How soon is too soon to consider market access strategies for my specialty drug?

The answer is that it’s never too soon, advises Craig Caceci, Managing Director at Terebellum. In fact, he says, if you want to ensure your product...

SCHOTT Pharma reveals strong financial performance in fiscal year 2022

In a record year of growth, sales increased by 27% to EUR 821 million and EBITDA by 33% to EUR 219 million on a preliminary basis

Pfizer enters into merger with Seagen

The companies expect to complete the transaction in late 2023 or early 2024, subject to fulfilment of customary closing conditions

BioNxt signs agreement to acquire novel solid oral drug dosage tech

"This coating system could significantly improve oral tablet and oral capsule drug delivery with more precise drug release and predictable dosing."

Can preventive care put an end to disease and virus outbreaks?

Healthcare shouldn’t be about treatment!

Brenntag signs multi-year partnership with Workday Human Capital

The chosen Workday HCM solution will be tailored and implemented in the course of 2023 to meet the needs of Brenntag

Veratrak raises £5.3m to accelerate growth

This is set to accelerate the launch of a new product, the Hub, by Veratrak, a supply chain management software that links systems across various o...

Addressing the pharmaceutical industry’s energy blind spots

Paul Walsh, General Manager at CIM, explores the major energy consumption challenges facing the UK’s pharmaceutical manufacturing and life science...

Deprecated Yen attracting renewed international interest in Japanese pharma

Half of all exhibitors at CPHI Japan are international as business links strengthen with Switzerland, Korea, USA and the UK

The legacy of COVID-19 on the pharmaceutical industry

Although the COVID-19 pandemic has by no means ended, many countries are now on the path to transitioning the virus to a state of endemicity. Yet,...

In Brief

How early stage life sciences companies can improve the odds of attracting funding

Scorpion Biological Services becomes Scorpius BioManufacturing to reflect expansion

Symbiosis announces £1 million investment in analytical testing capability

FCE Pharma

Bormioli Pharma issues its first ESG Report

Brenntag issues promissory note for $641m

BioForward - The 'Roadmap for Growth' Life Sciences Event

WuXi STA breaks ground for new pharmaceutical manufacturing facility in Middletown, Delaware

Besins acquires site in Belgium to prevent HRT supply line issues

Effective Pharmaceutical GMP Audits and Self-Inspections with NSF

ChargePoint Technology’s new facility expands into Europe

Humanigen and PCI partner to prepare for commercialisation in the UK

Gain immediate financial return for your surplus equipment

Effective Pharmaceutical GMP Audits and Self-Inspections with NSF

Croda announces new pharma business

Does medtech have a role to play in tackling the cost-of-living crisis?

AffyXell expands partnership with GenScript ProBio

Value-based Healthcare in Europe

F2G enters collaboration to commercialise antifungal agent

Bone Therapeutics enters reverse merger discussions with Medsenic

Bormioli Pharma presents a new, reinforced value proposition for the US market

BIO CEO & Investor Conference

Sygnature Discovery acquires Peak Proteins

Upperton Pharma receives ‘substantial’ investment from Inflexion

Yourway adds additional capacity for controlled ambient storage

Biotech and Money London 2016